Grifols, Talecris deal

Grifols plans to acquire fellow plasma protein company Talecris in a cash and stock deal that the companies said values

Read the full 206 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE